Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

Share · CNE000000F48 (XSHE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Hubei Biocause Pharmaceutical Co., Ltd.
No Price
Share Float & Liquidity
Free Float 31,85 %
Shares Float 1,56 B
Shares Outstanding 4,9 B
Invested Funds

The following funds have invested in Hubei Biocause Pharmaceutical Co., Ltd.:

Fund
iShares MSCI China UCITS ETF USD (Dist)
Vol. in million
0,18
Percentage (%)
0,0054 %
Company Profile for Hubei Biocause Pharmaceutical Co., Ltd. Share
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.

Company Data

Name Hubei Biocause Pharmaceutical Co., Ltd.
Company Hubei Biocause Pharmaceutical Co., Ltd.
Website https://www.biocause.com
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE000000F48
Asset Class Share
Sector Financial Services
Industry Insurance - Life
CEO Wenxia Zhou
Market Capitalization 8 Mrd.
Country China
Currency CNY
Employees 1,8 T
Address #122 Yangwan Road, 448000 Jingmen
IPO Date 1996-11-12
Dividends from 'Hubei Biocause Pharmaceutical Co., Ltd.'
Ex-Date Dividend per Share
30.05.2023 0,11 CNY
02.06.2022 0,005 CNY
04.06.2021 0,01 CNY
20.05.2020 0,10 CNY
26.09.2019 0,03 CNY
12.10.2018 0,03 CNY
08.06.2018 0,01 CNY
21.06.2017 0,03 CNY
14.04.2016 0,010 CNY
12.04.2010 0,02 CNY

Stock Splits

Date Split
12.04.2010 37:20
09.11.2005 33:25
12.06.2002 23:20
24.09.2001 3:2
23.05.2001 59649:50000
16.05.2000 6:5
07.09.1999 9:5
27.12.1996 2:1

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 000627.SZ
More Shares
Investors who hold Hubei Biocause Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
LBBW BAYN BOAP 16/23
LBBW BAYN BOAP 16/23 Bond
LLOYDS FONDS AG  WD19/22
LLOYDS FONDS AG WD19/22 Bond